Financhill
Back

RxSight Quote, Financials, Valuation and Earnings

RxSight Price Quote

$33.64
-0.03 (-11.91%)
(Updated: December 21, 2024 at 5:45 AM ET)

RxSight Key Stats

Sell
1
RxSight (RXST) is a Sell

Day range:
$33.03 - $36.20
52-week range:
$33.03 - $66.54
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
9.91
P/B ratio:
4.89%

Volume:
2.2M
Avg. volume:
836K
1-year change:
-11.74%
Market cap:
$1.4B
Revenue:
$89.1M
EPS:
$-0.82

How Much Does RxSight Make?

Data Unavailable

Is RxSight Growing As A Company?

Data Unavailable

RxSight Stock Price Performance

  • Did RxSight Stock Go Up Last Month?
    RxSight share price went down by -24.86% last month
  • Did RXST's Share Price Rise Over The Last Year?
    RXST share price fell by -11.74% over the past 1 year

What Is RxSight 52-Week High & Low?

  • What Is RxSight’s 52-Week High Share Price?
    RxSight has traded as high as $66.54 over the past 52 weeks
  • What Is RxSight’s 52-Week Low Share Price?
    RxSight has traded as low as $33.03 over the past 52 weeks

RxSight Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy RxSight?

Data Unavailable

Is RxSight Cash Flow Positive?

Data Unavailable

RxSight Return On Invested Capital

Data Unavailable

RxSight Earnings Date & Stock Price

  • What Is RxSight's Stock Price Today?
    A single share of RXST can be purchased today for 33.67
  • What Is RxSight’s Stock Symbol?
    RxSight trades on the nasdaq under the ticker symbol: RXST
  • When Is RxSight’s Next Earnings Date?
    The next quarterly earnings date for RxSight is scheduled on February 28, 2025
  • When Is RXST's next ex-dividend date?
    RxSight's next ex-dividend date is December 21, 2024
  • How To Buy RxSight Stock?
    You can buy RxSight shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

RxSight Competitors

  • Who Are RxSight's Competitors?
    Below is a list of companies who compete with RxSight or are related in some way:
    • Perspective Therapeutics Inc (CATX)
    • PROCEPT BioRobotics Corp (PRCT)
    • Retractable Technologies Inc (RVP)
    • Catheter Precision Inc (VTAK)
    • Xtant Medical Holdings Inc (XTNT)

RxSight Dividend Yield

Data Unavailable

RxSight Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 100%
Revenue: 59.08% 0.69%

Analyst Recommendations

Buy Recommendations: 5
Hold Recommendations: 2
Sell Recommendations: 0
Price Target: 58.00
Upside from Last Price: 72.26%

Major Shareholders

Data Unavailable